CBPO [China Biologic Products] 6-K: (Original Filing)

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

CBPO [China Biologic Products] 6-K: 18th Floor, Jialong International Building 19 Chaoyang Park

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

CBPO [China Biologic Products] 6-K: (Original Filing)

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

CBPO [China Biologic Products] 6-K: 18th Floor, Jialong International Building 19 Chaoyang Park

[18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2019 Dear Shareholder: Notice is hereby given that the annual general meeting of shareholders (the “An]

CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]

CBPO [China Biologic Products] 6-K: FOR RELEASE May 10, 2019 China Biologic Reports

[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]

CBPO [China Biologic Products] 6-K: (Original Filing)

[CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2019 EQUITY INCENTIVE PLAN 1. This Plan permits the Administrator to grant Options, Restricted Shares, Restricted Share Units, Share Appreciation Rights, and Other Share-Based Awards in order to retain, attract and motivate Employees, Directors and Consultants ]

CBPO [China Biologic Products] 6-K: CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2019 EQUITY INCENTIVE

[CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2019 EQUITY INCENTIVE PLAN 1. This Plan permits the Administrator to grant Options, Restricted Shares, Restricted Share Units, Share Appreciation Rights, and Other Share-Based Awards in order to retain, attract and motivate Employees, Directors and Consultants ]

Skip to toolbar